New Cell Therapy Shows Promise for Blood Cancer Patients

Bristol Myers Squibb reports encouraging results for a cutting-edge therapy helping multiple myeloma patients who've run out of options.

The CAR T-cell treatment offers fresh hope for those battling this challenging blood cancer.